RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      검색결과 좁혀 보기

      선택해제

      오늘 본 자료

      • 오늘 본 자료가 없습니다.
      더보기
      • 무료
      • 기관 내 무료
      • 유료
      • HCC Screening Program in Mongolia Single Center Data

        ( O. Baatarkhuu ),( B. Batdelger ),( D. Munkh-orshikh ),( J. Amarsanaa ) 대한간학회 2018 춘·추계 학술대회 (KASL) Vol.2018 No.1

        Aims: : Incidence of liver cancer in 4th rate of common cancers and 3rd rate of deaths due to cancer incidence in the world. In the Mongolia, cases of liver cancer are 44.1% of all cancer cases and mortalities are 43.3%, which is the first leading cause of mortality among cancer. In Mongolia, 81.2% of the liver cancer was diagnosed at an advanced stages (stage 3 or 4) and the 5-year survival rate (after diagnosed) of 19.5% are associated with lack of high risk population screening. The most common causes of liver cancer are hepatitis B, C and co infections. Screening and diagnosis in early stage of liver cancer in high risk population group Methods: In our study we used single center patient data. These patients are controlled in screening in early stage of liver cancer in Happy Veritas Clinic and Diagnostic Center. In this center, patients are included for HCC screening, when they have liver fibrosis stage higher than F2 (over 7.2kPa) that indicates higher likehood of developing HCC. Fibrosis stage was measured using a Fibroscan (Fibroscan 502 Touch, Echosens, Paris, France). The total number of patients included for screening was 10682 patients such as abdominal ultrasound and to identify serum AFP every 3 months. 181 patients were included in this study, who had complete set of data and are regularly controlled for screening in early stage of liver cancer. Medical history, results of blood test, liver function tests, AFP, liver fibrosis stage and abdominal ultrasound examination results were collected for each patient. Results: 181 patients with an average age of 54±11 (range 23- 89 years old) were included the study. In the result, causes of liver fibrosis were HCV 59.1%(107), hbv 24.9%(45), HBV/HDV 13.3%(24), HCV/HBV 2%(3), HCV/HBV/HDV 0.6%(1) and without hepatitis viruses 0.6%(1). According to the study F2 stage was 64.6%(117), F3 stage 27.1%(49) and F4 stage 8.3%(15). We studied the changes in laboratory tests and depending on the patients fibrosis stage. Increasing fibrosis stage of liver cirrhosis has decreased platelets aalbumin and total protein level (P<0,001). However, we observed ALT level, which increased in F3 stage and decreased fibrosis stage F4. Liver cancer nodule is detected in 4 patients from 181 patients during the follow-up. Those 4 patients had fibrosis stage F4 in Fibroscan analysis and average level of AFP was 86. Conclusions: We conclude that patients in F4 stage in Fibroscan analysis have higher risk of developing liver cancer. Therefore, health care providers need regularly screening and testing in early stage of liver cancer in high risk population.

      연관 검색어 추천

      이 검색어로 많이 본 자료

      활용도 높은 자료

      해외이동버튼